Dr. Weizer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Mount Sinai Medical Center
4300 Alton Rd
Miami Beach, FL 33140Phone+1 305-674-2957Fax+1 305-674-2408
Summary
- Dr. Alon Weizer is a Professor of Urology at Columbia and Chief Medical Officer at Mount Sinai Medical Center in Miami Beach. He received his medical degree from Baylor College of Medicine, his residency at Duke, and fellowship in Urologic Oncology at University of Michigan. He specializes in minimally invasive urologic oncology specializing in kidney, prostate, testis, and bladder cancer.
Education & Training
- Duke University HospitalResidency, Urology, 2001 - 2005
- Duke University HospitalResidency, Surgery, 1999 - 2001
- Baylor College of MedicineClass of 1999
Certifications & Licensure
- MI State Medical License 2004 - 2026
- FL State Medical License 2022 - 2025
- NC State Medical License 1999 - 2020
- American Board of Urology Urology
- American Association of Physician LeadershipCertified Physician Executive
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma Start of enrollment: 2009 Jan 01
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal Gel.Phillip M Pierorazio, Nir Kleinmann, Ahmad Shabsigh, Brian Hu, Jay D Raman
The Journal of Urology. 2024-12-02 - 1 citationsIntegrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response.Nathan M Merrill, Samuel D Kaffenberger, Liwei Bao, Nathalie Vandecan, Laura Goo
European Urology. 2024-11-01 - 1 citationsPositive surgical margins in partial nephrectomy: a collaborative effort to maintain surgical quality.Mohit Butaney, Samantha Wilder, Yuzhi Wang, Sonia Bhayani, Ji Qi
BJU International. 2024-03-01
Journal Articles
- Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic ImplicationsPetros Grivas, Phillip Palmbos, Ganesh Palapattu, Jeffrey S Montgomery, Alon Z Weizer, European Urology
- Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell CarcinomaAaron M Udager, Andrew S Mcdaniel, Simpa S Salami, Samuel D Kaffenberger, Jeffrey S Montgomery, Alon Z Weizer, Zachery R Reichert, Ajjai S Alva, Arul M Chinnaiyan, Sco..., European Urology
- Detailed Pathologic Analysis on the Co-Occurrence of Non-Seminomatous Germ Cell Tumor Subtypes in Matched Orchiectomy and Retroperitoneal Lymph Node DissectionsDavid Smith, Ganesh S Palapattu, Aaron Udager, Scott A Tomlins, Alon Z Weizer, Rohit Mehra, Angela Wu, Madelyn Lew, Jeffrey S Montgomery, Samuel D Kaffenberger, Khaled..., Medical Oncology
Authored Content
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
Press Mentions
- What's Next for Patient Care? Insights from 96 Healthcare ExecutivesDecember 3rd, 2024
- Bundled Cancer Payments Come with ChallengesJuly 7th, 2016
- U-M Cancer Center Selected for Innovative Care InitiativeJune 29th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: